Most of the early prostate cancer has no obvious symptoms, but its malignancy metastasis will cause largely deaths. The treatment options for patients with prostate cancer include traditional surgery, external beam th...Most of the early prostate cancer has no obvious symptoms, but its malignancy metastasis will cause largely deaths. The treatment options for patients with prostate cancer include traditional surgery, external beam therapy, hormone therapy, small molecular drug and cryosurgery. It was considered non-traditional treatments also can be used in alternative medicines for prostate cancer therapy. There are well-known molecular mechanisms and their pathogenesis, which provide potential targets for drug screening on the prostate cancer. Currently, natural plant extracts or human tissues active ingredients are widely used for the treatment of cancer. Then isolated effective substances in the extract, and further prepared large amounts of small molecule drugs by chemical synthesis. In this review, we summarized four small molecular drugs, abiraterone, docetaxel, isochaihulactone and butylidenephthalide, and their detailed anti-tumor mechanisms. These indicate that small molecular drug is a very efficient way and can be used for prostate cancer treatment.展开更多
目的运用网络药理学方法及分子对接技术探讨黄芪-半夏”药对治疗非小细胞肺癌(NSCLC)的作用机制。方法通过文献查找及TCMSP数据库筛选“黄芪-半夏”药对主要成分及作用靶点,在GeneCards、PharmGKB、DrugBank、OMIM数据库获取NSCLC相关靶...目的运用网络药理学方法及分子对接技术探讨黄芪-半夏”药对治疗非小细胞肺癌(NSCLC)的作用机制。方法通过文献查找及TCMSP数据库筛选“黄芪-半夏”药对主要成分及作用靶点,在GeneCards、PharmGKB、DrugBank、OMIM数据库获取NSCLC相关靶点,利用Cytoscape软件分别构建“中药-成分-靶点”“中药-成分-靶点-疾病”相互作用网络;运用STRING数据库构建蛋白互作网络,并根据拓扑学参数筛选“黄芪-半夏”药对治疗NSCLC的关键靶点;对关键靶点进行GO功能富集和KEGG通路分析,并构建“成分-靶点-通路”网络图,运用Auto Dock Vina 1.1.2将得到的主要活性成分与关键靶点进行分子对接,运用PyMOL软件进行结果可视化。结果共获得“黄芪-半夏”药对有效成分33个,作用于227个潜在靶点,NSCLC靶点1253个,拓扑分析得到关键靶点97个,其中度值≥中位数的靶点有48个,包括TP53、AKT1、CASP3、JUN等。GO功能富集分析得到生物过程主要涉及细胞因子介导的信号通路,基因表达的正向调控,RNA聚合酶II启动子转录的正调控;KEGG通路富集分析主要包括Pathways in cancer通路、肿瘤坏死因子信号通路、PI3K-Akt通路等,分子对接结果显示,“黄芪-半夏”药对主要活性化合物与5个核心靶点的结合能力皆良好。结论“黄芪-半夏”药对可能通过槲皮素、山奈酚、黄芩素等主要活性成分,作用于TP53、AKT1、CASP3、JUN、VEGFA等相关靶点,干预Pathways in cancer、肿瘤坏死因子、PI3K-Akt等信号通路,协同产生调控肿瘤细胞周期、介导肿瘤细胞凋亡、抑制其增殖分化及转移等来防治NSCLC。展开更多
Molecular self-assembly is very ordinary phenomenon in the biological process such as protein folding,DNA encoding and etc.Inspired by this inherent biological process,nanostructure such as nanofibers,nanosphere,and s...Molecular self-assembly is very ordinary phenomenon in the biological process such as protein folding,DNA encoding and etc.Inspired by this inherent biological process,nanostructure such as nanofibers,nanosphere,and so on formed by the therapeutic agents and its derivatives that can further self-assemble into supramolecular hydrogels have attained considerable attentions in the field of drug delivery due to its favorable features such as high and precise drug payload,carrier-free and excellent biocompatibility.Additionally,the prodrug hydrogelator can be rationally designed to fine-tune over its drug release behavior and degradation in response to various biological stimulus(temperature,p H,ionic strength and etc.).This review summarized and discussed the recent advancement in the self-assembled small molecular weight hydrogels of prodrugs.展开更多
文摘Most of the early prostate cancer has no obvious symptoms, but its malignancy metastasis will cause largely deaths. The treatment options for patients with prostate cancer include traditional surgery, external beam therapy, hormone therapy, small molecular drug and cryosurgery. It was considered non-traditional treatments also can be used in alternative medicines for prostate cancer therapy. There are well-known molecular mechanisms and their pathogenesis, which provide potential targets for drug screening on the prostate cancer. Currently, natural plant extracts or human tissues active ingredients are widely used for the treatment of cancer. Then isolated effective substances in the extract, and further prepared large amounts of small molecule drugs by chemical synthesis. In this review, we summarized four small molecular drugs, abiraterone, docetaxel, isochaihulactone and butylidenephthalide, and their detailed anti-tumor mechanisms. These indicate that small molecular drug is a very efficient way and can be used for prostate cancer treatment.
文摘目的运用网络药理学方法及分子对接技术探讨黄芪-半夏”药对治疗非小细胞肺癌(NSCLC)的作用机制。方法通过文献查找及TCMSP数据库筛选“黄芪-半夏”药对主要成分及作用靶点,在GeneCards、PharmGKB、DrugBank、OMIM数据库获取NSCLC相关靶点,利用Cytoscape软件分别构建“中药-成分-靶点”“中药-成分-靶点-疾病”相互作用网络;运用STRING数据库构建蛋白互作网络,并根据拓扑学参数筛选“黄芪-半夏”药对治疗NSCLC的关键靶点;对关键靶点进行GO功能富集和KEGG通路分析,并构建“成分-靶点-通路”网络图,运用Auto Dock Vina 1.1.2将得到的主要活性成分与关键靶点进行分子对接,运用PyMOL软件进行结果可视化。结果共获得“黄芪-半夏”药对有效成分33个,作用于227个潜在靶点,NSCLC靶点1253个,拓扑分析得到关键靶点97个,其中度值≥中位数的靶点有48个,包括TP53、AKT1、CASP3、JUN等。GO功能富集分析得到生物过程主要涉及细胞因子介导的信号通路,基因表达的正向调控,RNA聚合酶II启动子转录的正调控;KEGG通路富集分析主要包括Pathways in cancer通路、肿瘤坏死因子信号通路、PI3K-Akt通路等,分子对接结果显示,“黄芪-半夏”药对主要活性化合物与5个核心靶点的结合能力皆良好。结论“黄芪-半夏”药对可能通过槲皮素、山奈酚、黄芩素等主要活性成分,作用于TP53、AKT1、CASP3、JUN、VEGFA等相关靶点,干预Pathways in cancer、肿瘤坏死因子、PI3K-Akt等信号通路,协同产生调控肿瘤细胞周期、介导肿瘤细胞凋亡、抑制其增殖分化及转移等来防治NSCLC。
基金financially supported by grants from the National Natural Science Foundation of China(No.31671022)the Key Program for International S&T Cooperation Projects of China(No.2015DFA50310)the National Science and Technology Major Project(No.2014ZX09303301)
文摘Molecular self-assembly is very ordinary phenomenon in the biological process such as protein folding,DNA encoding and etc.Inspired by this inherent biological process,nanostructure such as nanofibers,nanosphere,and so on formed by the therapeutic agents and its derivatives that can further self-assemble into supramolecular hydrogels have attained considerable attentions in the field of drug delivery due to its favorable features such as high and precise drug payload,carrier-free and excellent biocompatibility.Additionally,the prodrug hydrogelator can be rationally designed to fine-tune over its drug release behavior and degradation in response to various biological stimulus(temperature,p H,ionic strength and etc.).This review summarized and discussed the recent advancement in the self-assembled small molecular weight hydrogels of prodrugs.